Global Digital Therapeutics Market Report 2021: COVID-19 Impacts, Changes and Growth to 2025 & 2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Digital Therapeutics Global Market Report 2021: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering. The global digital therapeu

Businesswire2021/11/02 10:36 ET

7 Healthcare Stocks to Add to Your Portfolio

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Healthcare stocks could take over from energy stocks as top dog during this defensive cycle as yields move higher and tech stocks lose value. The post 7 Healthcare Stocks to Add to Your Portfolio appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

InvestorPlace2021/10/06 14:21 ET

木材姉重鎮の遠隔医療の先駆者：価格設定モデルは賢明だが、なぜ保険を販売するか

Teladocはインターネット遠隔医療の草分けです。同社の強みは、米国市場の約三割のシェア、自社で構成される医師チームによる相対的にコントロールできるコスト、競合他社に比べるとより安い製品です。

市值風雲APP2021/04/22 01:23 ET

Why Goldman Sachs Is Waiting For Teladoc's Merger Story To Unfold

Teladoc Health Inc’s (NYSE: TDOC) acquisition of Livongo Health (NASDAQ: LVGO) was completed on Oct. 30 and has yet to generate impressive growth, according to Goldman Sachs. The Teladoc Health Analy

Benzinga Staff Writer2020/12/03 22:57 ET

Livongo Health Q3 Adj. EPS $0.16 Beats $0.05 Estimate, Sales $106.10M Beat $98.80M Estimate

Livongo Health (NASDAQ:LVGO) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.05 by 220 percent. This is a 420 percent increase over losses of $(0.05) per

Benzinga Real-time News2020/10/28 16:28 ET

Livongo Health Cut to Neutral From Overweight by Piper Sandler

DJ Livongo Health Cut to Neutral From Overweight by Piper Sandler Ratings actions from Benzinga: https://www.benzinga.com/stock/LVGO/ratings (END) Dow Jones Newswires October 28, 2020 05:30

Dow Jones Newswires2020/10/28 05:30 ET